Clinician Scientist Fellow (4 posts)

The MRC Medicines Development Fellowship Scheme offers a unique opportunity for four Clinician Scientist Fellows (CSFs) to develop into independent cross-boundary research leaders. The successful candidates will plan and deliver a five-year research project in collaboration with an industry partner supported by one of four universities.  The research projects will need to be consistent with the MRC criteria for excellence in research.  This is a bespoke scheme offering ¿without walls¿ training that will cover the full medicines development pathway. The scheme will support medical fellows to become future leaders in either industry or academia. Training will ensure that Fellows develop a cohesive, cross-boundary, programme of work, within a scheme that pro-actively engages industry partners, creating a seamless and supportive working environment which enhances multi-sector mobility and porosity between academia and industry.

The combination of four universities (Queen Mary University London, University of Glasgow, University of Liverpool and University of Manchester) and four industry partners (GSK, AstraZeneca, Optum and Hammersmith Medicines Research) will provide a unique powerfully synergistic environment for the Fellows, allowing integration of expertise and technologies across academic and industry partners, and across all phases of drug development. The Fellows will be able to interact with the large cohorts of clinical and fundamental science trainees in the four Universities, including on UKRI Doctoral Training Partnership schemes, and with scientists in Industry. Fellows will have access to modern clinical research facilities in the Institutions, and access to state-of-the-art technologies through all the partners.

Each Fellow will have a nominated sponsor in their university and another one in industry. In addition, specific advice and support will be given by members of the Programme Management Board. In addition, Fellows will receive mentorship from senior academics and in turn Clinician Scientists will be expected act as a mentor for one of the schemes¿ Pre-doctoral Clinical Research Fellows (based at another HEI). Mentor training will be provided. The scheme will also have a bespoke teaching programme that will be responsive to the Fellow¿s specific learning needs and developments in the research environment and at the cutting edge of discovery.

The expected start date for the successful candidates is 1st March 2025. Candidates should hold their CCT either at the time of appointment or should expect to achieve this within 6 months of appointment. However, candidates should be no more than two years post CCT.

Initial enquires to be addressed to the Programme Manager, Miss Angela Foxcroft, email:  [email protected] and will be redirected as appropriate to University/industry leads.

Please note that by submitting an application for this role you are providing consent for the University of Liverpool to share your application and the personal information provided to our partners on this scheme: Queen Mary University London, the University of Manchester, the University of Glasgow, Astra Zenca, GSK, Optum and Hammersmith Research Ltd. This is for the purpose of assessing your suitability for the role (shortlisting and interview).

Please note the closing date for this role has been extended to 02 June 2024.